Related Experiment Video
Updated: Jun 24, 2026
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Profiling activities of transcription factors in breast cancer cell lines
Xin Jiang1, Leslie Roth, Chunfai Lai
1Panomics, Inc., Fremont, CA 94555, USA. xjiang@panomics.com
Abstract:
Transcription factors (TFs) are critical regulators of cell growth and differentiation, whose dysfunction is associated with many human diseases, including cancer. To facilitate the discovery of functionally altered TFs among the approximately 2,000 human TFs, we (Panomics, Inc., Fremont, CA) developed a Protein/DNA array technology that can be used to profile the activities of multiple TFs simultaneously. In this study, we applied this technology to examine the TF activities in three different breast cancer cell lines: MCF7 (estrogen receptor [ER] +, tamoxifen-sensitive), T47D (ER+, tamoxifen-resistant), and HCC1806 (ER-, tamoxifen-resistant). We compared the differences in TF activity in these cells lines following treatment with estradiol or tamoxifen. We found a number of TF activities unique to each of these cell lines. In addition to verifying previous findings, the novel findings of this study provide a more comprehensive view of the differences in the response of these cancer lines to estrogen and tamoxifen.
Insights
This study used a novel Protein/DNA array to profile transcription factor (TF) activities in breast cancer cell lines. Researchers identified unique TF activities in response to estrogen and tamoxifen, offering new insights into cancer cell behavior.
Area of Science:
- Molecular Biology
- Cancer Research
- Genomics
Background:
- Transcription factors (TFs) regulate crucial cellular processes like growth and differentiation.
- TF dysfunction is implicated in various human diseases, notably cancer.
- Profiling TF activity aids in understanding disease mechanisms and developing targeted therapies.
Purpose of the Study:
- To develop and apply a Protein/DNA array technology for simultaneous profiling of multiple human transcription factor activities.
- To investigate and compare transcription factor activities in three distinct breast cancer cell lines (MCF7, T47D, HCC1806).
- To analyze the impact of estradiol and tamoxifen treatments on TF activity in these cell lines.
Main Methods:
- Development of a novel Protein/DNA array for high-throughput TF activity profiling.
- Application of the array to analyze TF activities in MCF7, T47D, and HCC1806 breast cancer cell lines.
- Comparative analysis of TF activity profiles before and after treatment with estradiol or tamoxifen.
Main Results:
- Identification of distinct transcription factor activity patterns unique to each breast cancer cell line.
- Demonstration of differential TF responses to estradiol and tamoxifen treatments across the cell lines.
- Validation of previously known TF activities and discovery of novel TF alterations.
Conclusions:
- The Protein/DNA array technology effectively profiles TF activities in cancer cells.
- Significant differences in TF activities exist among breast cancer subtypes and in response to hormonal therapies.
- These findings provide a comprehensive view of TF dysregulation in breast cancer and its response to treatment.
Related Concept Videos
02:23Master Transcription Regulators
01:30General Transcription Factors